相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette et al.
DRUGS (2022)
Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial
Elizabeth A. Thiele et al.
EPILEPSIA (2022)
Pharmacokinetic Profile of Δ9-Tetrahydrocannabinol, Cannabidiol, and Metabolites in Blood Following Vaporization and Oral Ingestion of Cannabidiol Products.
Cecilia L. Bergeria et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2022)
The Synaptic Interactions of Alcohol and the Cannabinoid
Sarah A. Wolfe et al.
ALCOHOL RESEARCH-CURRENT REVIEWS (2022)
Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats
Paola Maccioni et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch et al.
PSYCHOPHARMACOLOGY (2021)
ALCOHOL USE DISORDER: THE ROLE OF MEDICATION IN RECOVERY
Barbara J. Mason et al.
ALCOHOL RESEARCH-CURRENT REVIEWS (2021)
Gender differences in the effects of cannabidiol on ethanol binge drinking in mice
Adrian Viudez-Martinez et al.
ADDICTION BIOLOGY (2020)
Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?
Abdullah Al Shoyaib et al.
PHARMACEUTICAL RESEARCH (2020)
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C. Michael White
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Cannabidiol Adverse Effects and Toxicity
Marilyn A. Huestis et al.
CURRENT NEUROPHARMACOLOGY (2019)
Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system
Ana Martin-Sanchez et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Orrin Devinsky et al.
EPILEPSIA (2019)
Evaluation of Mifepristone Effects on Alcohol-Seeking and Self-Administration in Baboons
August F. Holtyn et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
Alcohol-related peripheral neuropathy: a systematic review and meta-analysis
Thomas Julian et al.
JOURNAL OF NEUROLOGY (2019)
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Lara A. Ray et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Psychiatric comorbidities in alcohol use disorder
Alvaro Castillo-Carniglia et al.
LANCET PSYCHIATRY (2019)
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
Gustavo Gonzalez-Cuevas et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabidiol reduces ethanol consumption, motivation and relapse in mice
Adrian Viudez-Martinez et al.
ADDICTION BIOLOGY (2018)
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury
Yuping Wang et al.
SCIENTIFIC REPORTS (2017)
Baclofen and naltrexone effects on alcohol self-administration: Comparison of treatment initiated during abstinence or ongoing alcohol access in baboons
August F. Holtyn et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Effects of the benzodiazepine GABA(A) alpha 1-preferring antagonist 3-isopropoxy-beta-carboline hydrochloride (3-ISOPBC) on alcohol seeking and self-administration in baboons
August F. Holtyn et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
Shanna Babalonis et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Cannabidiol, neuroprotection and neuropsychiatric disorders
Alline C. Campos et al.
PHARMACOLOGICAL RESEARCH (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther M. Blessing et al.
NEUROTHERAPEUTICS (2015)
Baclofen effects on alcohol seeking, self-administration and extinction of seeking responses in a within-session design in baboons
Angela N. Duke et al.
ADDICTION BIOLOGY (2014)
The Effects of Varenicline on Alcohol Seeking and Self-Administration in Baboons
Barbara J. Kaminski et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)
Differences in Extinction of Cue-Maintained Conditioned Responses Associated with Self-Administration: Alcohol Versus a Nonalcoholic Reinforcer
August F. Holtyn et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
Lili Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
Daniel J. Liput et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Effects of the benzodiazepine GABAA α1-preferring ligand, 3-propoxy-β-carboline hydrochloride (3-PBC), on alcohol seeking and self-administration in baboons
Barbara J. Kaminski et al.
PSYCHOPHARMACOLOGY (2013)
Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboons
Barbara J. Kaminski et al.
PSYCHOPHARMACOLOGY (2012)
Dissociation of alcohol-seeking and consumption under a chained schedule of oral alcohol reinforcement in baboons
Barbara J. Kaminski et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Environmental cues, alcohol seeking, and consumption in baboons: Effects of response requirement and duration of alcohol abstinence
Elise M. Weerts et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Involvement of the endocannabinoid system in drug addiction
R Maldonado et al.
TRENDS IN NEUROSCIENCES (2006)
Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity
C Hamelink et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure
LJ Jolivette et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats
S Serra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats
S Serra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
分享论文
